- Home
- CRVS vs JILL Comparison
CRVS vs JILL Comparison
Compare CRVS & JILL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- JILL
- Stock Information
- Founded
- CRVS 2014
- JILL 1959
- Country
- CRVS United States
- JILL United States
- Employees
- CRVS N/A
- JILL N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- JILL Clothing/Shoe/Accessory Stores
- Sector
- CRVS Health Care
- JILL Consumer Discretionary
- Exchange
- CRVS Nasdaq
- JILL Nasdaq
- Market Cap
- CRVS 451.0M
- JILL 375.1M
- IPO Year
- CRVS 2016
- JILL 2017
- Fundamental
- Price
- CRVS $8.95
- JILL $26.29
- Analyst Decision
- CRVS Buy
- JILL Strong Buy
- Analyst Count
- CRVS 4
- JILL 7
- Target Price
- CRVS $12.83
- JILL $38.17
- AVG Volume (30 Days)
- CRVS 1.0M
- JILL 97.1K
- Earning Date
- CRVS 11-12-2024
- JILL 12-03-2024
- Dividend Yield
- CRVS N/A
- JILL 1.06%
- EPS Growth
- CRVS N/A
- JILL 36.69
- EPS
- CRVS N/A
- JILL 2.83
- Revenue
- CRVS N/A
- JILL $614,539,000.00
- Revenue This Year
- CRVS N/A
- JILL $3.03
- Revenue Next Year
- CRVS N/A
- JILL $3.57
- P/E Ratio
- CRVS N/A
- JILL $9.30
- Revenue Growth
- CRVS N/A
- JILL 1.62
- 52 Week Low
- CRVS $1.30
- JILL $23.06
- 52 Week High
- CRVS $10.00
- JILL $40.61
- Technical
- Relative Strength Index (RSI)
- CRVS 60.45
- JILL 58.42
- Support Level
- CRVS $8.02
- JILL $24.04
- Resistance Level
- CRVS $8.71
- JILL $27.12
- Average True Range (ATR)
- CRVS 0.78
- JILL 0.83
- MACD
- CRVS -0.13
- JILL 0.06
- Stochastic Oscillator
- CRVS 52.70
- JILL 73.93
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the critical cellular elements of the immune system. It focuses on the development of immune modulator product candidates to treat COVID-19, T-cell lymphomas, other cancers, and autoimmune diseases. The company's primary product candidate is Soquelitinib (CPI-818), an oral, small-molecule drug that selectively inhibits ITK (interleukin-2-inducible T cell kinase). The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About JILL J. Jill Inc.
J.Jill Inc is a national lifestyle brand that provides apparel, footwear, and accessories. The company's products are marketed under the J.Jill brand name and sold through two channels: its e-commerce platform and catalog (Direct) and its retail stores (Retail). Revenue is derived from the sale of apparel and accessory merchandise through the company's Retail and Direct channels, which include website and catalog phone orders. Revenue also includes shipping and handling fees collected from customers.